ComPAKT: A Phase I trial of olaparib in combination with AZD5363

• Research type

  Research Study

• Full title

  ComPAKT: A Phase I multi-centre trial of the combination of olaparib (PARP inhibitor) and AZD5363 (AKT inhibitor) in patients with advanced solid tumours.

• IRAS ID

  141317

• Contact name

  Johann De Bono

• Contact email

  johann.de-bono@icr.ac.uk

• Sponsor organisation

  Clinical Research and Development, Royal Marsden NHS Foundation Trust

• Eudract number

  2013-004692-13

• ISRCTN Number

  not provided

• REC name

  London - Central Research Ethics Committee

• REC reference

  14/LO/0103

• Date of REC Opinion

  12 Mar 2014

• REC opinion

  Further Information Favourable Opinion